HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jes Olesen Selected Research

Pain-Free

1/2021Evidence of localized and widespread pressure pain hypersensitivity in patients with tension-type headache: A systematic review and meta-analysis.
2/2012Chronic migraine--classification, characteristics and treatment.
3/2004Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jes Olesen Research Topics

Disease

126Migraine Disorders (Migraine)
11/2023 - 01/2003
66Headache (Headaches)
01/2023 - 09/2002
28Pain (Aches)
11/2023 - 01/2003
14Migraine without Aura (Common Migraine)
01/2023 - 01/2003
11Hypersensitivity (Allergy)
06/2023 - 09/2008
11Migraine with Aura (Familial Hemiplegic Migraine)
01/2018 - 03/2006
10Epilepsy (Aura)
11/2023 - 09/2008
4Hypoxia (Hypoxemia)
01/2019 - 12/2014
3Tension-Type Headache (Tension Headache)
01/2021 - 11/2008
3Photophobia (Light Sensitivity)
01/2018 - 03/2004
3Cluster Headache (Cluster Headaches)
11/2016 - 11/2008
2Constipation
05/2022 - 01/2020
2Hyperalgesia
01/2021 - 01/2020
2Trigeminal Neuralgia (Tic Douloureux)
01/2019 - 02/2015
2Ischemia
07/2018 - 01/2018
2Infarction (Infarctions)
07/2018 - 01/2018
2Headache Disorders (Headache Syndromes)
01/2018 - 03/2006
2Inflammation (Inflammations)
12/2015 - 11/2011
2Nausea
11/2014 - 03/2004
2Neurogenic Inflammation
06/2013 - 08/2010
2Acute Pain
08/2010 - 06/2005
2Myalgia
06/2005 - 01/2003
2Intracranial Vasospasm
12/2004 - 04/2004
1Primary Headache Disorders
01/2022
1Alzheimer Disease (Alzheimer's Disease)
10/2020

Drug/Important Bio-Agent (IBA)

32Calcitonin Gene-Related PeptideIBA
11/2023 - 03/2004
18Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
06/2023 - 01/2009
18Sumatriptan (Imigran)FDA LinkGeneric
12/2022 - 04/2011
17Nitroglycerin (Dynamite)FDA LinkGeneric
01/2022 - 11/2008
16Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2021 - 03/2004
15Tryptamines (Triptans)IBA
01/2023 - 10/2006
15Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 01/2003
12ProstaglandinsIBA
12/2021 - 01/2003
10Cromakalim (Levcromakalim)IBA
06/2023 - 01/2019
10Adenylyl Cyclases (Adenylyl Cyclase)IBA
01/2023 - 01/2011
9Adenosine Triphosphate (ATP)IBA
02/2023 - 01/2003
9KATP ChannelsIBA
02/2023 - 01/2019
9Cilostazol (Pletal)FDA LinkGeneric
01/2022 - 12/2004
9olcegepantIBA
01/2021 - 11/2004
7NeuropeptidesIBA
11/2023 - 09/2008
7Vasodilator Agents (Vasodilators)IBA
01/2018 - 09/2008
6Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
05/2022 - 11/2004
6Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2005
5Peptides (Polypeptides)IBA
01/2023 - 01/2011
5Messenger RNA (mRNA)IBA
01/2022 - 11/2010
5RNA (Ribonucleic Acid)IBA
01/2021 - 07/2007
5Dinoprostone (PGE2)FDA Link
02/2017 - 09/2010
5Prostaglandins EIBA
08/2012 - 01/2003
4PotassiumIBA
02/2023 - 10/2019
4Monoclonal AntibodiesIBA
01/2023 - 04/2018
4Histamine (Histamine Dihydrochloride)FDA Link
03/2019 - 01/2003
4Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
02/2017 - 01/2011
4Serotonin (5 Hydroxytryptamine)IBA
04/2012 - 01/2003
3AnkyrinsIBA
11/2023 - 08/2019
3AntibodiesIBA
05/2022 - 12/2019
3isosorbide-5-mononitrate (Ismo)FDA LinkGeneric
01/2022 - 08/2008
3Pain-FreeIBA
01/2021 - 03/2004
3Analgesics (Analgesic Drugs)IBA
12/2019 - 10/2010
3salicylhydroxamic acid (SHAM)IBA
01/2019 - 03/2016
3Carbon MonoxideIBA
11/2018 - 12/2014
3Pemetrexed (MTA)FDA Link
01/2018 - 03/2006
3Phosphodiesterase 3 InhibitorsIBA
11/2014 - 04/2004
3Type A Botulinum Toxins (Botox)FDA Link
02/2012 - 11/2010
3Epoprostenol (Prostacyclin)FDA LinkGeneric
11/2011 - 09/2008
3telcagepantIBA
04/2011 - 12/2009
3EnzymesIBA
11/2010 - 10/2003
3Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
07/2009 - 04/2004
3Sildenafil Citrate (Viagra)FDA Link
10/2005 - 09/2002
3Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
10/2005 - 09/2002
2Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 01/2021
25-HT1F Serotonin ReceptorIBA
01/2022 - 06/2012
2TRPA1 Cation ChannelIBA
12/2021 - 10/2020
2Histamine Antagonists (Antihistamines)IBA
03/2019 - 01/2019
2Retinaldehyde (Retinal)IBA
07/2018 - 01/2018
2Glutamic Acid (Glutamate)FDA Link
03/2016 - 06/2005
2Guanosine Monophosphate (5' Guanylic Acid)IBA
12/2014 - 01/2003
2Cyclic AMP (AMP, Cyclic)IBA
11/2014 - 04/2004
2Topiramate (Topamax)FDA LinkGeneric
05/2012 - 02/2012
2Proteins (Proteins, Gene)FDA Link
01/2012 - 11/2010
2tonabersatIBA
06/2011 - 08/2009
2ProdrugsIBA
04/2010 - 11/2008
2Phosphates (Orthophosphate)IBA
04/2010 - 01/2003
2Ion Channels (Ion Channel)IBA
11/2008 - 08/2006
2omega-N-Methylarginine (NG Monomethyl L Arginine)IBA
11/2008 - 10/2003
2Adenosine (Adenocard)FDA LinkGeneric
09/2008 - 01/2003
2BradykininIBA
06/2005 - 01/2003
1CalciumIBA
11/2023
1Sodium Channels (Sodium Channel)IBA
11/2023
1XenobioticsIBA
11/2023
1Environmental Pollutants (Pollutants, Environmental)IBA
11/2023
1Glutamine (L-Glutamine)FDA Link
01/2023
1Contraceptive Agents (Contraceptives)IBA
01/2023
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2022
1ElementsIBA
11/2022
1SolutionsIBA
01/2021

Therapy/Procedure

9Therapeutics
01/2023 - 02/2012
8Intravenous Infusions
02/2017 - 10/2010
6Aftercare (After-Treatment)
01/2023 - 04/2011
2Precision Medicine
12/2019 - 04/2019
2Microvascular Decompression Surgery
01/2019 - 02/2015